Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuball

Showing results (151-160 of 256) with videos related to

Pageof 26
Sort By:
Bone Marrow Transplantation|September 6, 2023
Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP)N Worel, P Ljungman, I C M Verheggen, et al.
Bone Marrow Transplantation|October 25, 2019
Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMTThomas Heinicke, Myriam Labopin, Emmanuelle Polge, et al.
Heliyon|March 18, 2020
Age-dependent increase in Thy-1 protein in the rat supraoptic nucleusJason M Askvig, Talia S Dalzell, Nadia Toumeh, et al.
Journal of Hematology & Oncology|May 4, 2021
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemiaBhagirathbhai Dholaria, Myriam Labopin, Jaime Sanz, et al.
Oncotarget|April 2, 2016
High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelated donors for acute myeloid leukemia - an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationTomasz Czerw, Myriam Labopin, Christoph Schmid, et al.
Journal of Thrombosis and Haemostasis : JTH|May 31, 2012
The circulating platelet count is not dictated by the liver, but may be determined in part by the bone marrow: analyses from human liver and stem cell transplantationsT Lisman, G Pittau, F J T Leite, et al.
Hepatology (Baltimore, Md.)|January 22, 2017
Activation of silent mating type information regulation 2 homolog 1 by human chorionic gonadotropin exerts a therapeutic effect on hepatic injury and inflammationCaroline Steinmetz, Anubha Kashyap, Nataliya Zhivkova, et al.
Blood|July 7, 2012
Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subsetChristelle Harly, Yves Guillaume, Steven Nedellec, et al.
Bone Marrow Transplantation|February 8, 2019
The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapiesJakob R Passweg, Helen Baldomero, Grzegorz W Basak, et al.
Journal for Immunotherapy of Cancer|April 5, 2024
Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AMLVania Lo Presti, Angelo Meringa, Ester Dunnebach, et al.
Pageof 26

Showing results (151-160 of 256) with videos related to

Sort By:
Pageof 26
Bone Marrow Transplantation|September 6, 2023
Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP)N Worel, P Ljungman, I C M Verheggen, et al.
Bone Marrow Transplantation|October 25, 2019
Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMTThomas Heinicke, Myriam Labopin, Emmanuelle Polge, et al.
Heliyon|March 18, 2020
Age-dependent increase in Thy-1 protein in the rat supraoptic nucleusJason M Askvig, Talia S Dalzell, Nadia Toumeh, et al.
Journal of Hematology & Oncology|May 4, 2021
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemiaBhagirathbhai Dholaria, Myriam Labopin, Jaime Sanz, et al.
Oncotarget|April 2, 2016
High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelated donors for acute myeloid leukemia - an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationTomasz Czerw, Myriam Labopin, Christoph Schmid, et al.
Journal of Thrombosis and Haemostasis : JTH|May 31, 2012
The circulating platelet count is not dictated by the liver, but may be determined in part by the bone marrow: analyses from human liver and stem cell transplantationsT Lisman, G Pittau, F J T Leite, et al.
Hepatology (Baltimore, Md.)|January 22, 2017
Activation of silent mating type information regulation 2 homolog 1 by human chorionic gonadotropin exerts a therapeutic effect on hepatic injury and inflammationCaroline Steinmetz, Anubha Kashyap, Nataliya Zhivkova, et al.
Blood|July 7, 2012
Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subsetChristelle Harly, Yves Guillaume, Steven Nedellec, et al.
Bone Marrow Transplantation|February 8, 2019
The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapiesJakob R Passweg, Helen Baldomero, Grzegorz W Basak, et al.
Journal for Immunotherapy of Cancer|April 5, 2024
Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AMLVania Lo Presti, Angelo Meringa, Ester Dunnebach, et al.
Pageof 26